Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Referral from vascular surgery to cardiovascular rehabilitation and related outcomes in patients with peripheral arterial disease: the THINKPAD-RELOADED survey.

Ambrosetti M, Faggiano P, Greco C, Mureddu GF, Temporelli PL, Pedretti RFE.

Monaldi Arch Chest Dis. 2019 Sep 18;89(3). doi: 10.4081/monaldi.2019.1101.

2.

Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry.

Bonapace S, Rossi A, Laroche C, Crespo-Leiro MG, Piepoli MF, Coats AJS, Dahlström U, Malek F, Macarie C, Temporelli PL, Maggioni AP, Tavazzi L; European Society of Cardiology Heart Failure Long-Term Registry Investigators group.

ESC Heart Fail. 2019 Dec 9. doi: 10.1002/ehf2.12537. [Epub ahead of print]

3.

Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries.

Tilz RR, Dagres N, Arbelo E, Blomström-Lundqvist C, Crijns HJ, Kirchhof P, Kautzner J, Temporelli PL, Laroche C, Roberts PR, Pehrson S, Lip GYH, Brugada J, Tavazzi L.

Europace. 2019 Nov 26. pii: euz291. doi: 10.1093/europace/euz291. [Epub ahead of print]

PMID:
31768523
4.

Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction.

Scardovi AB, De Maria R, Galeotti GG, Faggiano P, Arcari L, Ghio S, Temporelli PL, Rossi A, Magni G, Simioniuc A, Ricci R, Dini FL.

Monaldi Arch Chest Dis. 2019 Jul 18;89(2). doi: 10.4081/monaldi.2019.1045.

5.

Additive Value of Biomarkers and Echocardiography to Stratify the Risk of Death in Heart Failure Patients with Reduced Ejection Fraction.

Falletta C, Clemenza F, Klersy C, Agnese V, Bellavia D, Di Gesaro G, Minà C, Romano G, Temporelli PL, Dini FL, Rossi A, Raineri C, Turco A, Traversi E, Ghio S.

Cardiol Res Pract. 2019 May 2;2019:1824816. doi: 10.1155/2019/1824816. eCollection 2019.

6.

Four golden rules to halve the risk of cardiovascular events.

Temporelli PL.

Eur Heart J Suppl. 2019 Mar;21(Suppl B):B103-B104. doi: 10.1093/eurheartj/suz022. Epub 2019 Mar 29. No abstract available.

7.

Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association.

Temporelli PL, Tilz RR, Arbelo E, Dagres N, Laroche C, Crijns HJ, Blomstrom-Lundqvist C, Kirchhof P, Lip GYH, Boriani G, Pokushalov E, Nakou E, Brugada J, Tavazzi L.

Eur J Heart Fail. 2019 May;21(5):690-693. doi: 10.1002/ejhf.1458. Epub 2019 Mar 21. No abstract available.

PMID:
30896056
8.

Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study.

De Luca L, Temporelli PL, Riccio C, Gonzini L, Marinacci L, Tartaglione SN, Costa P, Scherillo M, Senni M, Colivicchi F, Gulizia MM; START Investigators .

Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):334-342. doi: 10.1093/ehjqcco/qcz002.

PMID:
30649303
9.

Correction: Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.

Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M, Raineri C, Scelsi L, Pistono M, Totaro R, Guida S, Visconti LO.

PLoS One. 2018 Dec 4;13(12):e0208863. doi: 10.1371/journal.pone.0208863. eCollection 2018.

10.

Cardiac Prevention and Rehabilitation "3.0": From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR).

Pedretti RFE, Fattirolli F, Griffo R, Ambrosetti M, Angelino E, Brazzo S, Corrà U, Dasseni N, Faggiano P, Favretto G, Febo O, Ferrari M, Giallauria F, Greco C, Iannucci M, La Rovere MT, Mallardo M, Mazza A, Piepoli M, Riccio C, Scalvini S, Tavazzi L, Temporelli PL, Mureddu GF.

Monaldi Arch Chest Dis. 2018 Oct 26;88(3):1004. doi: 10.4081/monaldi.2018.1004.

11.

[Cardiac rehabilitation "3.0": from the acute to the chronic stage. A position paper from the Italian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)].

Pedretti RFE, Fattirolli F, Griffo R, Ambrosetti M, Angelino E, Brazzo S, Corrà U, Dasseni N, Faggiano P, Favretto G, Febo O, Ferrari M, Giallauria F, Greco C, Iannucci M, La Rovere MT, Mallardo M, Mazza A, Piepoli M, Riccio C, Scalvini S, Tavazzi L, Temporelli PL, Mureddu GF.

G Ital Cardiol (Rome). 2018 Oct;19(10 Suppl 3):3S-40S. doi: 10.1714/3001.30010. Italian.

PMID:
30353206
12.

Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes.

Mantovani A, Rigolon R, Turino T, Pichiri I, Falceri A, Rossi A, Temporelli PL, Bonapace S, Lippi G, Zoppini G, Bonora E, Byrne CD, Targher G.

Diabetes Metab. 2018 Dec;44(6):473-481. doi: 10.1016/j.diabet.2018.08.007. Epub 2018 Sep 5.

PMID:
30195089
13.

Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.

De Luca L, Arca M, Temporelli PL, Colivicchi F, Gonzini L, Lucci D, Bosco B, Callerame M, Lettica GV, Di Lenarda A, Gulizia MM; START Investigators.

Clin Cardiol. 2018 Aug;41(8):1075-1083. doi: 10.1002/clc.23031. Epub 2018 Aug 20.

14.

Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study.

De Luca L, Temporelli PL, Lucci D, Colivicchi F, Calabrò P, Riccio C, Amico A, Mascia F, Proia E, Di Lenarda A, Gulizia MM; START Investigators.

PLoS One. 2018 Jul 12;13(7):e0199770. doi: 10.1371/journal.pone.0199770. eCollection 2018.

15.

Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.

Nodari S, Butler J, Temporelli PL.

JAMA Cardiol. 2018 Aug 1;3(8):781. doi: 10.1001/jamacardio.2018.1309. No abstract available.

PMID:
29874369
16.

Refined 4-group classification of left ventricular hypertrophy based on ventricular concentricity and volume dilatation outlines distinct noninvasive hemodynamic profiles in a large contemporary echocardiographic population.

Barbieri A, Rossi A, Gaibazzi N, Erlicher A, Mureddu GF, Frattini S, Faden G, Manicardi M, Beraldi M, Agostini F, Lazzarini V, Moreo A, Temporelli PL, Faggiano P.

Echocardiography. 2018 Sep;35(9):1258-1265. doi: 10.1111/echo.14031. Epub 2018 May 23.

PMID:
29797430
17.

Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.

Mantovani A, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI-HF Investigators.

Metabolism. 2018 Jun;83:205-215. doi: 10.1016/j.metabol.2018.02.007. Epub 2018 Mar 29.

PMID:
29477817
18.

Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.

Rossi A, Dini FL, Agricola E, Faggiano P, Benfari G, Temporelli PL, Cucco C, Scelsi L, Vassanelli C, Ghio S.

J Echocardiogr. 2018 Dec;16(4):155-161. doi: 10.1007/s12574-018-0373-9. Epub 2018 Feb 23.

PMID:
29476388
19.

Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.

Arca M, Borghi C, Pontremoli R, De Ferrari GM, Colivicchi F, Desideri G, Temporelli PL.

Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):197-205. doi: 10.1016/j.numecd.2017.11.001. Epub 2017 Nov 13. Review.

20.

Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.

Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M, Raineri C, Scelsi L, Pistono M, Totaro R, Guida S, Oltrona Visconti L.

PLoS One. 2017 Nov 27;12(11):e0188383. doi: 10.1371/journal.pone.0188383. eCollection 2017. Erratum in: PLoS One. 2018 Dec 4;13(12):e0208863.

21.

Searching for the holy grail of cardiovascular prevention.

Temporelli PL.

Eur J Prev Cardiol. 2018 Jan;25(2):154-156. doi: 10.1177/2047487317744725. Epub 2017 Nov 20. No abstract available.

PMID:
29154678
22.

Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.

Ghio S, Crimi G, Temporelli PL, Traversi E, La Rovere MT, Cannito A, Vizza D, Scelsi L, Raineri C, Guazzi M, Oltrona Visconti L.

Eur J Heart Fail. 2018 Apr;20(4):725-734. doi: 10.1002/ejhf.1067. Epub 2017 Nov 16.

23.

Current management and treatment of patients with stable coronary artery diseases presenting to cardiologists in different clinical contexts: A prospective, observational, nationwide study.

De Luca L, Temporelli PL, Lucci D, Gonzini L, Riccio C, Colivicchi F, Geraci G, Formigli D, Maras P, Falcone C, Di Lenarda A, Gulizia MM; START Investigators.

Eur J Prev Cardiol. 2018 Jan;25(1):43-53. doi: 10.1177/2047487317740663. Epub 2017 Nov 10.

PMID:
29124952
24.

Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.

Canepa M, Straburzynska-Migaj E, Drozdz J, Fernandez-Vivancos C, Pinilla JMG, Nyolczas N, Temporelli PL, Mebazaa A, Lainscak M, Laroche C, Maggioni AP, Piepoli MF, Coats AJS, Ferrari R, Tavazzi L; ESC-HFA Heart Failure Long-Term Registry Investigators.

Eur J Heart Fail. 2018 Jan;20(1):100-110. doi: 10.1002/ejhf.964. Epub 2017 Sep 26.

25.

Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.

Adir Y, Guazzi M, Offer A, Temporelli PL, Cannito A, Ghio S.

Am Heart J. 2017 Oct;192:120-127. doi: 10.1016/j.ahj.2017.06.006. Epub 2017 Jun 21.

PMID:
28938958
26.

Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.

Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI‐HF Investigators.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005156. doi: 10.1161/JAHA.116.005156.

27.

ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy.

Riccio C Coordinator, Gulizia MM Facc Fesc Coordinator, Colivicchi F Facc Fesc Coordinator, Di Lenarda A Facc Fesc Coordinator, Musumeci G, Faggiano PM, Abrignani MG, Rossini R, Fattirolli F, Valente S, Mureddu GF, Temporelli PL, Olivari Z, Amico AF, Casolo G Facc Fesc, Fresco C, Menozzi A, Nardi F Facc Fesc.

Eur Heart J Suppl. 2017 May;19(Suppl D):D163-D189. doi: 10.1093/eurheartj/sux021. Epub 2017 May 2.

28.

[Heart rate as a therapeutic target after acute coronary syndrome and in chronic coronary heart disease].

Ambrosetti M, Scardina G, Favretto G, Temporelli PL, Faggiano PM, Greco C, Pedretti RF.

G Ital Cardiol (Rome). 2017 Mar;18(3 Suppl 1):3S-16S. doi: 10.1714/2685.27479. Italian.

PMID:
28492564
29.

Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.

Rossi A, Inciardi RM, Rossi A, Temporelli PL, Lucci D, Gonzini L, Marchioli R, Nicolosi GL, Tavazzi L; GISSI-HF Investigators.

Pulm Pharmacol Ther. 2017 Jun;44:16-23. doi: 10.1016/j.pupt.2017.03.001. Epub 2017 Mar 3.

PMID:
28263812
30.

Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.

Dauriz M, Targher G, Laroche C, Temporelli PL, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro M, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L; ESC-HFA Heart Failure Long-Term Registry.

Diabetes Care. 2017 May;40(5):671-678. doi: 10.2337/dc16-2016. Epub 2017 Mar 2.

PMID:
28255009
31.

Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.

Griffo R, Spanevello A, Temporelli PL, Faggiano P, Carone M, Magni G, Ambrosino N, Tavazzi L; SUSPIRIUM Investigators.

Eur J Prev Cardiol. 2017 Apr;24(6):567-576. doi: 10.1177/2047487316687425. Epub 2017 Jan 9.

PMID:
28067533
32.

Jogging and mortality: is there a U-shaped curve?

Temporelli PL.

J Cardiovasc Med (Hagerstown). 2017 Jan;18 Suppl 1:e177-e179. doi: 10.2459/JCM.0000000000000467. No abstract available.

PMID:
27922930
33.

Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function.

Dini FL, Simioniuc A, Carluccio E, Ghio S, Rossi A, Biagioli P, Reboldi G, Galeotti GG, Lu F, Zara C, Whalley G, Temporelli PL.

Data Brief. 2016 Nov 9;9:1074-1076. eCollection 2016 Dec.

34.

Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.

Ghio S, Guazzi M, Scardovi AB, Klersy C, Clemenza F, Carluccio E, Temporelli PL, Rossi A, Faggiano P, Traversi E, Vriz O, Dini FL; all investigators.

Eur J Heart Fail. 2017 Jul;19(7):873-879. doi: 10.1002/ejhf.664. Epub 2016 Nov 17.

35.

In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.

Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro MG, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L; ESC-HFA HF Long-Term Registry investigators.

Eur J Heart Fail. 2017 Jan;19(1):54-65. doi: 10.1002/ejhf.679. Epub 2016 Oct 28.

36.

Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.

Simioniuc A, Carluccio E, Ghio S, Rossi A, Biagioli P, Reboldi G, Galeotti GG, Lu F, Zara C, Whalley G, Temporelli PL, Dini FL; investigators of the Network Labs Ultrasound (NEBULA) in Heart Failure Study Group.

Int J Cardiol. 2016 Dec 1;224:416-423. doi: 10.1016/j.ijcard.2016.09.034. Epub 2016 Sep 18.

PMID:
27690339
37.

[Role of omega-3 polyunsaturated fatty acids after acute coronary syndrome].

Temporelli PL, Buda S, Greene SJ.

G Ital Cardiol (Rome). 2016 Jul-Aug;17(7 Suppl 1):3-10. doi: 10.1714/2336.25080. Italian.

PMID:
27729661
38.

Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction.

Dini FL, Carluccio E, Simioniuc A, Biagioli P, Reboldi G, Galeotti GG, Raineri C, Gargani L, Scelsi L, Mandoli GE, Cannito A, Rossi A, Temporelli PL, Ghio S; Network Labs Ultrasound (NEBULA) in Heart Failure Study Group.

Eur J Heart Fail. 2016 Dec;18(12):1462-1471. doi: 10.1002/ejhf.639. Epub 2016 Sep 20.

39.

Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial.

Canepa M, Temporelli PL, Rossi A, Rossi A, Gonzini L, Nicolosi GL, Staszewsky L, Marchioli R, Maggioni AP, Tavazzi L; GISSI-HF Investigators.

Cardiology. 2017;136(2):128-137. doi: 10.1159/000448166. Epub 2016 Sep 8.

PMID:
27618363
40.

[ANMCO/GICR-IACPR/SICI-GISE Consensus document: Clinical management of patients with stable coronary artery disease].

Riccio C, Gulizia MM, Colivicchi F, Di Lenarda A, Musumeci G, Faggiano PM, Abrignani MG, Rossini R, Fattirolli F, Valente S, Mureddu GF, Temporelli PL, Olivari Z, Amico AF, Casolo G, Fresco C, Menozzi A, Nardi F.

G Ital Cardiol (Rome). 2016 Jul-Aug;17(7-8):529-69. doi: 10.1714/2330.25050. Italian.

PMID:
27571333
41.

Functional mitral regurgitation: are we treating the real target?

Benfari G, Dandale R, Rossi A, Onorati F, Mugnai G, Ribichini F, Temporelli PL, Vassanelli C.

J Cardiovasc Med (Hagerstown). 2016 Nov;17(11):767-73. doi: 10.2459/JCM.0000000000000429. Review.

PMID:
27541360
42.

Cardiopulmonary rehabilitation in patiens with heart failure and chronic pulmonary disease.

Temporelli PL.

Monaldi Arch Chest Dis. 2016 Jun 22;84(1-2):739. doi: 10.4081/monaldi.2015.739.

43.

[Physical activity and cardiovascular health].

Temporelli PL.

G Ital Cardiol (Rome). 2016 Mar;17(3):176-80. doi: 10.1714/2190.23654. Italian.

PMID:
27029874
44.

Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction.

Greene SJ, Temporelli PL, Campia U, Vaduganathan M, Degli Esposti L, Buda S, Veronesi C, Butler J, Nodari S.

Am J Cardiol. 2016 Feb 1;117(3):340-6. doi: 10.1016/j.amjcard.2015.10.050. Epub 2015 Nov 18.

PMID:
26708689
45.

Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.

Targher G, Dauriz M, Tavazzi L, Temporelli PL, Lucci D, Urso R, Lecchi G, Bellanti G, Merlo M, Rossi A, Maggioni AP; IN-HF Outcome Investigators.

Int J Cardiol. 2016 Jan 15;203:587-93. doi: 10.1016/j.ijcard.2015.10.207. Epub 2015 Nov 11.

PMID:
26574932
46.

A retrospective multicenter study on long-term prevalence of chronic pain after cardiac surgery.

Marcassa C, Faggiano P, Greco C, Ambrosetti M, Temporelli PL; Italian Association of Cardiovascular Prevention, Rehabilitation (GICR-IACPR).

J Cardiovasc Med (Hagerstown). 2015 Nov;16(11):768-74. doi: 10.2459/JCM.0000000000000271. Erratum in: J Cardiovasc Med (Hagerstown). 2015 Dec;16(12):857. Claudio, Marcassa [corrected to Marcassa, Claudio]; Pompilio, Faggiano [corrected to Faggiano, Pompilio]; Cesare, Greco [corrected to Greco, Cesare]; Marco, Ambrosetti [corrected to Ambrosetti, Marco]; Luigi, Temporelli Pier [corrected to Temporelli, Pier.

PMID:
26258718
47.

[Italian cardiologists and tobacco smoking. A survey on the prevalence and knowledge of smoking and strategies for smoking cessation in a cohort of Italian cardiologists].

Frisinghelli A, Cesana F, Clavario P, Mureddu GF, Temporelli PL, Cherubini A, Mocini D, Fioravanti P, Fattirolli F.

G Ital Cardiol (Rome). 2015 Jul-Aug;16(7-8):426-32. doi: 10.1714/1954.21244. Italian.

PMID:
26228612
48.

[Nonsteroid anti-inflammatory drugs (NSAID) and risk of cardiovascular events. Literature review and clinical implications].

Temporelli PL, Zito GB, Pedretti RF, Belisarii FI, Putortí G, Faggiano P; Gruppo Italiano di Cardiologia Preventiva e Riabilitative (GICR-IACPR); Associazioni Regionali Cardiologi Ambulatoriali (ARCA).

Monaldi Arch Chest Dis. 2014 Sep;82(3):165-70. Review. Italian.

49.

Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis.

Rossi A, Temporelli PL, Cicoira M, Gaibazzi N, Cioffi G, Nistri S, Magatelli M, Tavazzi L, Faggiano P.

Int J Cardiol. 2015;190:15-7. doi: 10.1016/j.ijcard.2015.04.083. Epub 2015 Apr 15. No abstract available.

PMID:
25912110
50.

[The serotonin syndrome: why should cardiologists be aware and scared of it].

Temporelli PL, Boccanelli A, Desideri G, Faggiano P, Mora G, Oliva F, Terrosu P.

G Ital Cardiol (Rome). 2015 Jan;16(1):34-43. doi: 10.1714/1776.19248. Review. Italian.

PMID:
25689750

Supplemental Content

Loading ...
Support Center